Transglutaminase 2 up-regulation is associated with RANKL/OPG pathway in cultured HPDL cells and THP-1-differentiated macrophages

[1]  R. Ientile,et al.  Differential expression of transglutaminase genes in patients with chronic periodontitis. , 2014, Oral diseases.

[2]  D. Milardi,et al.  Transforming Growth Factor Beta 1 and Vascular Endothelial Growth Factor Levels in the Pathogenesis of Periodontal Disease , 2013 .

[3]  G. Anastasi,et al.  Immunohistochemical analysis of TGF-β1 and VEGF in gingival and periodontal tissues: a role of these biomarkers in the pathogenesis of scleroderma and periodontal disease. , 2012, International journal of molecular medicine.

[4]  N. Bostanci,et al.  The RANKL-OPG system in clinical periodontology. , 2012, Journal of clinical periodontology.

[5]  K. Mehta,et al.  Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer. , 2010, Biochemical pharmacology.

[6]  K. Wenger,et al.  Periodontal ligament fibroblasts sustain destructive immune modulators of chronic periodontitis. , 2010, Journal of periodontology.

[7]  C. Ohlsson,et al.  RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis. , 2010, Bone.

[8]  Sung-Hwan Park,et al.  IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways. , 2010, Immunology letters.

[9]  S. Ghosh,et al.  The NF-kappaB family of transcription factors and its regulation. , 2009, Cold Spring Harbor perspectives in biology.

[10]  H. Lee,et al.  Effects of nicotine on antioxidant defense enzymes and RANKL expression in human periodontal ligament cells. , 2009, Journal of periodontology.

[11]  D. Mercola,et al.  Expression profile of human gingival fibroblasts induced by interleukin-1beta reveals central role of nuclear factor-kappa B in stabilizing human gingival fibroblasts during inflammation. , 2009, Journal of periodontology.

[12]  N. Bostanci,et al.  Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. , 2007, Journal of periodontal research.

[13]  P. Kostenuik,et al.  RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. , 2007, Journal of periodontology.

[14]  P. Eke,et al.  Case Definitions for Use in Population-Based Surveillance of Periodontitis. , 2007, Journal of periodontology.

[15]  R. Ientile,et al.  Tissue transglutaminase and the stress response , 2007, Amino Acids.

[16]  I. Ishikawa,et al.  Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. , 2007, Periodontology 2000.

[17]  Soo-Youl Kim,et al.  Transglutaminase 2 in inflammation. , 2006, Frontiers in bioscience : a journal and virtual library.

[18]  R. Ientile,et al.  Increased transglutaminase activity was associated with IL-6 release in cultured human gingival fibroblasts exposed to dental cast alloys , 2006, Amino Acids.

[19]  M. Kaartinen,et al.  Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[20]  G. Li Volti,et al.  Antioxidant treatment inhibited glutamate-evoked NF-kappaB activation in primary astroglial cell cultures. , 2005, Neurotoxicology.

[21]  T. Lallier,et al.  Transcript profiling of periodontal fibroblasts and osteoblasts. , 2005, Journal of periodontology.

[22]  N. Lang,et al.  New formation of periodontal tissues around titanium implants in a novel dentin chamber model. , 2005, Clinical oral implants research.

[23]  G. Belibasakis,et al.  Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin. , 2005, Cytokine.

[24]  David Haynes,et al.  Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. , 2003, Journal of periodontal research.

[25]  S. Gross,et al.  Importance of tissue transglutaminase in repair of extracellular matrices and cell death of dermal fibroblasts after exposure to a solarium ultraviolet A source. , 2003, The Journal of investigative dermatology.

[26]  Robert M. Graham,et al.  Transglutaminases: crosslinking enzymes with pleiotropic functions , 2003, Nature Reviews Molecular Cell Biology.

[27]  Rita Casadio,et al.  Transglutaminases: nature's biological glues. , 2002, The Biochemical journal.

[28]  Y. Kuboki,et al.  [Bone matrix proteins]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.

[29]  M. Zern,et al.  TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells. , 1998, The American journal of physiology.

[30]  M. Zern,et al.  TNF-α modulates expression of the tissue transglutaminase gene in liver cells. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[31]  S. Socransky,et al.  Gram negative species associated with active destructive periodontal lesions. , 1985, Journal of clinical periodontology.

[32]  S. Condello,et al.  Transglutaminase 2 and phospholipase A2 interactions in the inflammatory response in human Thp-1 monocytes , 2013, Amino Acids.

[33]  D. Telci,et al.  Tissue transglutaminase (TG2)--a wound response enzyme. , 2006, Frontiers in bioscience : a journal and virtual library.

[34]  N. Pavlos,et al.  Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. , 2003, International journal of molecular medicine.

[35]  T. Kawai,et al.  Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. , 2001, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[36]  M. McKee,et al.  The Osteoporosis Primer: Bone matrix proteins , 2000 .